Mason v. Federal Express Corp.

165 F. Supp. 3d 832, 2016 WL 706163, 2016 U.S. Dist. LEXIS 21331
CourtDistrict Court, D. Alaska
DecidedFebruary 22, 2016
Docket3:14-cv-0107 JWS
StatusPublished
Cited by5 cases

This text of 165 F. Supp. 3d 832 (Mason v. Federal Express Corp.) is published on Counsel Stack Legal Research, covering District Court, D. Alaska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mason v. Federal Express Corp., 165 F. Supp. 3d 832, 2016 WL 706163, 2016 U.S. Dist. LEXIS 21331 (D. Alaska 2016).

Opinion

ORDER AND OPINION

[Re: Motions at dockets 55 and 57]

JOHN W. SEDWICK, SENIOR UNITED STATES DISTRICT JUDGE

I. MOTIONS PRESENTED

At docket 55 plaintiff Maurice K. Mason (“Mason”) moves for judgment after a trial on the record pursuant to Federal Rule of Civil Procedure (“Rule”) 52 or, alternatively, summary judgment pursuant to Rule 56. Defendants Federal Express Corporation, FedEx Trade Networks Transport & Brokerage, Inc., Aetna Life Insurance Company, Federal Express Corporation Short Term Disability Plan, and Federal Express Corporation Long Term Disability Plan (collectively, “Defendants”) oppose Mason’s motion at docket 58 and cross-move for summary judgment at docket 57. These two filings are supported by a memorandum at docket 59. Mason replies in support of his motion at docket 66 and opposes Defendants’ cross-motion at dock[836]*836et 67. Mason’s memorandum in support of these two filings is at docket 64, and his declaration is at docket 65. At docket 73 Defendants reply in support of their cross-motion.

Oral argument was not requested and would not assist the court.

II. BACKGROUND

While he was employed by defendant FedEx Trade Networks Transport & Brokerage, Inc. (“FedEx Trade”) Mason was diagnosed with a rare autoimmune disease known as Stiff Person Syndrome (“SPS”). SPS is “manifested clinically by the continuous isometric contraction of many of the somatic muscles; contractions are usually forceful and painful and most frequently involve the trunk musculature, although limb muscles may be involved.”1 After defendant Aetna Life Insurance Company (“Aetna”) denied his claim for short-term disability benefits, he filed suit under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).2 His complaint alleges: (1) wrongful denial of his claim for short-term disability benefits; (2) wrongful refusal to consider his claim for long-term disability benefits; (3) breach of fiduciary duty; and (4) failure to provide requested plan documents. Although the parties style their cross-motions as summary judgment motions, they would be more accurately described as partial summary judgment motions because they only address the merits of the first of Mason’s four causes of action: whether Aetna abused its discretion in denying Mason’s short-term disability claim.

Mason argues that Aetna abused its discretion by ignoring objective medical evidence in the record that shows that his SPS and the side effects of his medications prevent him from performing the duties of his former job. The following is a summary of the evidence in the record.

A. Initial Treatment from Medical Park Family Care

Beginning in early 2008 Mason repeatedly complained about muscle spasms to his primary care physicians at Medical Park Family Care,3 but the physicians were unable to determine their cause.4 For example, Mason saw Dr. James R. Lord on May 8, 2009, complaining of “continuing [837]*837very unusual symptoms,” including “various types of body spasms in the hands, legs, feet”; “some cramping”; swollen joints; and blurred vision.5 Dr. Lord stated that Mason’s symptoms were “very difficult to explain.”6

B. SPS Diagnosis from the VA

In February 2010 Mason saw neurologist Gregg Meekins, M.D. with the VA Medical Center. Dr. Meekins noted Mason’s lengthy history “of severe spasms affecting hands, feet, torso, etc.,” and the multiple medications that Mason was taking “without benefit or .intolerable side effects of excessive sedation.”7 Dr. Meekins ordered laboratory testing, which “came back positive for very high anti-glutamic acid decarboxylase [“GAD”] 65 antibody level consistent with the diagnosis of stiff-person’s syndrome.”8 After diagnosing Mason with SPS, he prescribed baclofen to treat Mason’s condition.9 Although a subsequent laboratory test in July 2010 came back normal,10 Mason’s blood was retested in December 2010 and the results were positive for SPS (“although not as high a level” as the February result).11 Defendants do not contest the validity of Mason’s SPS diagnosis.

C. Consult with Neurologist Wayne Downs, M.D.

Mason met with neurologist Wayne Downs, M.D. in April 2010. Mason described his history of cramping, which he said had gotten gradually worse.12 He also explained that he was being treated with several “potentially sedating drugs” which caused a “lack of focus and short-term memory loss.”13 Mason told Dr. Downs that he was not able to perform his job and in “the last few days he [had] been found asleep at his desk on two occasions.”14

Dr. Downs assessed Mason as having “anti-GAD65 stiff person syndrome.” As to Mason’s 'lack of focus and memory loss, Dr. Downs stated that Mason’s encephalopathy15 was “worse on his current medications” and suspected that this was because of the baclofen he was taking. At the time Mason was taking 60 mg of baclofen daily.16 Dr. Downs wrote that “[w]ere 1 treating him I would taper the baclofen off relatively rapidly and then start pushing the .Valium.”17 “If we can get him off his sedating medications and he is still having an encephalopathic problem,” Dr. Downs wrote, “then I think a neuropsychological] test would be indicated to quantitate [sic] this as this may be a source of employment difficulties.”18

D.Follow-Up Treatment

Following his consult with Dr. Downs, Mason returned to Medical Park Family Care complaining about the side effects of his medications. On May 7, 2010 Dr. Lord ordered Mason to taper off baclofen but stated that he would still “likely need high [838]*838doses of muscle relaxants for the muscle cramps and stiffness.”19

On July 8, 2010 Mason saw Dr. Lord again, complaining that his SPS was worsening and that the tapering of the dosage of his muscle relaxants was not helping.20 The notes from Dr. Lord’s physical examination state that Mason was in “moderate páin/distress” and “[visibly uncomfortable, some palpable spasms on chest wall, discomfort with walking and changing positions.”21

On July 15, 2010, Mason was admitted to the emergency department of Providence Alaska Medical Center, complaining of cramps and muscle spasms with pain that he described as a 10 on a scale of 0 to 10.22 The emergency department physician noted that Mason did not appear to be in distress or discomfort despite his stated pain level, and that he was alert and oriented. Mason was given morphine and Ati-van for his pain and instructed to follow up with his primary care physician.23

The next morning Mason met with Dr. Lord, who noted in his physical exam that Mason was suffering from “moderate pain/distress.”24

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
165 F. Supp. 3d 832, 2016 WL 706163, 2016 U.S. Dist. LEXIS 21331, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mason-v-federal-express-corp-akd-2016.